VBL Therapeutics (VBLT) – Analyst Ratings
-
Chardan Capital Markets Downgrades Vascular Biogenics Ltd (VBLT) to Neutral
-
Oppenheimer Downgrades Vascular Biogenics Ltd (VBLT) to Perform
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to VBLT Stock Lookup